Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.
Herrero-Morant A, Martín-Varillas JL, Castañeda S, Maíz O, Sánchez J, Ortego N, Raya E, Prior-Español Á, Moriano C, Melero-González RB, Graña-Gil J, Urruticoechea-Arana A, Ramos-Calvo Á, Loredo-Martínez M, Salgado-Pérez E, Sivera F, Torre I, Narváez J, Andreu JL, Martínez-González O, Torre RG, Fernández-Aguado S, Romero-Yuste S, González-Mazón Í, Álvarez-Reguera C, Hernández JL, González-Gay MÁ, Blanco R; Neurobehçet Spanish Collaborative Group. Herrero-Morant A, et al. Among authors: alvarez reguera c. Rheumatology (Oxford). 2022 Nov 2;61(11):4427-4436. doi: 10.1093/rheumatology/keac097. Rheumatology (Oxford). 2022. PMID: 35166821 Review.
Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain.
Suárez-Amorín G, Demetrio-Pablo R, Fernández-Ramón R, Herrero-Morant A, Álvarez-Reguera C, Sánchez-Bilbao L, Martínez-López D, Martín-Varillas JL, Castañeda S, González-Gay MA, Blanco R. Suárez-Amorín G, et al. Among authors: alvarez reguera c. Clin Exp Rheumatol. 2023 Oct;41(10):1991-1997. doi: 10.55563/clinexprheumatol/z32rhm. Epub 2023 Apr 21. Clin Exp Rheumatol. 2023. PMID: 37083163 Free article.
Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review.
Calvo-Río V, Sánchez-Bilbao L, Álvarez-Reguera C, Castañeda S, González-Mazón I, Demetrio-Pablo R, González-Gay MA, Blanco R. Calvo-Río V, et al. Among authors: alvarez reguera c. Ther Adv Musculoskelet Dis. 2022 Nov 19;14:1759720X221137126. doi: 10.1177/1759720X221137126. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 36419482 Free PMC article.
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Martín-Varillas JL, González-López E, Gutiérrez-Larrañaga M, San Segundo D, Demetrio-Pablo R, Ocejo-Vinyals G, González-Gay MA, Blanco R. Álvarez-Reguera C, et al. Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221093211. doi: 10.1177/1759720X221093211. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35510170 Free PMC article.
Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review.
Martínez-López D, Ferraz-Amaro I, Prieto-Peña D, Sánchez-Bilbao L, Herrero-Morant A, Álvarez-Reguera C, Benavides-Villanueva F, Corrales-Selaya C, Trigueros-Vázquez M, González-Gay MÁ, Blanco R. Martínez-López D, et al. Among authors: alvarez reguera c. Front Med (Lausanne). 2022 Dec 12;9:1056374. doi: 10.3389/fmed.2022.1056374. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36579150 Free PMC article.
Single-center study on features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Batlle-López A, Fernández-López S, Paz-Gandiaga N, Blanco R. Álvarez-Reguera C, et al. Eur J Intern Med. 2023 Dec 2:S0953-6205(23)00416-8. doi: 10.1016/j.ejim.2023.11.019. Online ahead of print. Eur J Intern Med. 2023. PMID: 38044168
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
Herrero-Morant A, Álvarez-Reguera C, Martín-Varillas JL, Calvo-Río V, Casado A, Prieto-Peña D, Atienza-Mateo B, Maiz-Alonso O, Blanco A, Vicente E, Rúa-Figueroa Í, Cáceres-Martin L, García-Serrano JL, Callejas-Rubio JL, Ortego-Centeno N, Narváez J, Romero-Yuste S, Sánchez J, Estrada P, Demetrio-Pablo R, Martínez-López D, Castañeda S, Hernández JL, González-Gay MÁ, Blanco R. Herrero-Morant A, et al. Among authors: alvarez reguera c. J Clin Med. 2020 Aug 11;9(8):2608. doi: 10.3390/jcm9082608. J Clin Med. 2020. PMID: 32796717 Free PMC article.